AFFITOPE AD02
4 trials in this asset. Source: ClinicalTrials.gov, as of July 21, 2026.
Trials
4
Ongoing
0
Recruiting
0
Completed
3
Sites
32
Countries
6
Endpoints
8
Composite endpoints
0
Distinct sites and countries across this asset's trials. A site running several of its trials counts once, matching the map. All 8 linked ClinicalTrials.gov endpoints are classified into the categories below. Trial and endpoint linkage does not by itself establish treatment attribution for every endpoint.
Development
Where the program stands
Trials by phase
Trials by status
Evidence coverage
What this asset has been measured on
Endpoints grouped into outcome categories, ranked by how often they are measured across this asset's trials.
Most-measured metrics
Top 20 metrics across this asset's endpoints
Normalized metric codes are available for 4 of 8 classified ClinicalTrials.gov endpoints for this asset; the ranking below covers that coded subset.
2
2
Trials
Trials for this asset
Every trial for this asset, with the same search, filters, and sort as the Trials tab.
4 of 4
| Asset / Disease area | Key I/E criterion | Evidence | ||||||
|---|---|---|---|---|---|---|---|---|
| NCT01117818Clinical- and Immunological Activity, Safety and Tolerability of Different Doses / Formulations of AFFITOPE AD02 in Early Alzheimer's Disease | AFFITOPE AD02 Alzheimer’s disease | Alzheimer's disease | Ph 2 | Completed | 31 | Dec 2013 | 1 | |
| NCT02008513Follow-up Study to Assess Safety and Clinical Activity of Continued AFFITOPE® AD02 Vaccinations of Patients Who Participated in AFF006 | AFFITOPE AD02 Alzheimer’s disease | Age 50-85 | Ph 2 | Terminated | 27 | Sep 2014 | - | |
| NCT00633841Tolerability and Safety of Subcutaneous Administration of AFFITOPE AD02 in Mild to Moderate Alzheimer's Disease | AFFITOPE AD02 Alzheimer’s disease | Alzheimer's disease | Ph 1 | Completed | 1 | Sep 2009 | - | |
| NCT01093664Safety/Tolerability, Immunological and Clinical Activity of a Boost Immunization With AFFITOPE AD02 | AFFITOPE AD02 Alzheimer’s disease | Age 50-85 | Ph 1 | Completed | 1 | Jul 2010 | - |
Showing 1-4 of 4 trials